Colonic Immune Stimulation by Targeted Oral Vaccine

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kathania, Mahesh ^a   Zadeh, Mojgan ^a   Lightfoot, Yaíma L ^a   Roman, Robert M ^a   Sahay, Bikash ^a   Abbott, Jeffrey R ^a   Mohamadzadeh, Mansour ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; LACTOBACILLUS VACCINE; LECTIN RECEPTOR; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG DOSE INCREASE; DRUG MEGADOSE; GENE EXPRESSION; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; LACTOBACILLUS GASSERI; MACROPHAGE; MOUSE; NONHUMAN; PATTERN RECOGNITION; PROTEIN EXPRESSION;

ADMINISTRATION, ORAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; COLON; CYTOKINES; DENDRITIC CELLS; IMMUNITY, HUMORAL; LACTOBACILLUS; MACROPHAGES; MICE; MICE, INBRED C57BL; RECEPTORS, PATTERN RECOGNITION; SAFETY; T-LYMPHOCYTE SUBSETS; VACCINATION; VACCINES, SUBUNIT;

EID: 84873801431     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055143     Document Type: Article

References (34)

1. Sansonetti PJ, (2004) War and peace at mucosal surfaces. Nat Rev Immunol 4: 953-964.
2. Holmgren J, Czerkinsky C, (2005) Mucosal immunity and vaccines. Nat Med 11: S45-53.
3. Roberts M, Chatfield S, Pickard D, Li J, Bacon A, (2000) Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors. Infect Immun 68: 6041-6043.
4. Stevenson A, Roberts M, (2003) Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens. FEMS Immunol Med Microbiol 37: 121-128.
5. Saklani-Jusforgues H, Fontan E, Soussi N, Milon G, Goossens PL, (2003) Enteral immunization with attenuated recombinant Listeria monocytogenes as a live vaccine vector: organ-dependent dynamics of CD4 T lymphocytes reactive to a Leishmania major tracer epitope. Infect Immun 71: 1083-1090.
6. Mercenier A, Pavan S, Pot B, (2003) Probiotics as biotherapeutic agents: present knowledge and future prospects. Curr Pharm Des 9: 175-191.
7. Wells JM, Mercenier A, (2008) Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol 6: 349-362.
8. Christensen HR, Frokiaer H, Pestka JJ, (2002) Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168: 171-178.
9. Mohamadzadeh M, Olson S, Kalina WV, Ruthel G, Demmin GL, et al. (2005) Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A 102: 2880-2885.
10. Mohamadzadeh M, Duong T, Sandwick SJ, Hoover T, Klaenhammer TR, (2009) Dendritic cell targeting of Bacillus anthracis protective antigen expressed by Lactobacillus acidophilus protects mice from lethal challenge. Proc Natl Acad Sci U S A 106: 4331-4336.
11. Mohamadzadeh M, Durmaz E, Zadeh M, Pakanati KC, Gramarossa M, et al. (2010) Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine. Future Microbiol 5: 1289-1296.
12. Mohamadzadeh M, Pfeiler EA, Brown JB, Zadeh M, Gramarossa M, et al. (2011) Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc Natl Acad Sci U S A 108 (Suppl 1): 4623-4630.
13. Rogler G, Hausmann M, Vogl D, Aschenbrenner E, Andus T, et al. (1998) Isolation and phenotypic characterization of colonic macrophages. Clin Exp Immunol 112: 205-215.
14. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M, (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31: 321-330.
15. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ishigame H, et al. (2010) Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32: 681-691.
16. Tournier JN, Ulrich RG, Quesnel-Hellmann A, Mohamadzadeh M, Stiles BG, (2009) Anthrax, toxins and vaccines: a 125-year journey targeting Bacillus anthracis. Expert Rev Anti Infect Ther 7: 219-236.
17. Friedlander AM, Pittman PR, Parker GW, (1999) Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. JAMA 282: 2104-2106.
18. Welkos SL, Keener TJ, Gibbs PH, (1986) Differences in susceptibility of inbred mice to Bacillus anthracis. Infect Immun 51: 795-800.
19. Flick-Smith HC, Eyles JE, Hebdon R, Waters EL, Beedham RJ, et al. (2002) Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice. Infect Immun 70: 2022-2028.
20. Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, et al. (2007) Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge. Infect Immun 75: 4020-4029.
21. Pouwels PH, Leer RJ, Shaw M, Heijne den Bak-Glashouwer MJ, Tielen FD, et al. (1998) Lactic acid bacteria as antigen delivery vehicles for oral immunization purposes. Int J Food Microbiol 41: 155-167.
22. Tournier JN, Mohamadzadeh M, (2010) Key roles of dendritic cells in lung infection and improving anthrax vaccines. Trends Mol Med 16: 303-312.
23. Erskine CL, Krco CJ, Hedin KE, Borson ND, Kalli KR, et al. (2011) MHC class II epitope nesting modulates dendritic cell function and improves generation of antigen-specific CD4 helper T cells. Journal of immunology 187: 316-324.
24. Mohamadzadeh M, Duong T, Hoover T, Klaenhammer TR, (2008) Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria. Expert Rev Vaccines 7: 163-174.
25. Glomski IJ, Corre JP, Mock M, Goossens PL, (2007) Cutting Edge: IFN-gamma-producing CD4 T lymphocytes mediate spore-induced immunity to capsulated Bacillus anthracis. J Immunol 178: 2646-2650.
26. Schroder K, Hertzog PJ, Ravasi T, Hume DA, (2004) Interferon-gamma: an overview of signals, mechanisms and functions. Journal of leukocyte biology 75: 163-189.
27. Sakaguchi S, Yamaguchi T, Nomura T, Ono M, (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787.
28. Datta SK, Sabet M, Nguyen KP, Valdez PA, Gonzalez-Navajas JM, et al. (2010) Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A 107: 10638-10643.
29. Lee JB, Jang JE, Song MK, Chang J, (2009) Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PloS one 4: e5190.
30. Dickinson EC, Gorga JC, Garrett M, Tuncer R, Boyle P, et al. (1998) Immunoglobulin A supplementation abrogates bacterial translocation and preserves the architecture of the intestinal epithelium. Surgery 124: 284-290.
31. Welkos S, Little S, Friedlander A, Fritz D, Fellows P, (2001) The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology 147: 1677-1685.
32. Mohamadzadeh M, Klaenhammer TR, (2008) Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Expert Rev Vaccines 7: 1155-1164.
33. Chen G, Shaw MH, Kim YG, Nunez G, (2009) NOD-like receptors: role in innate immunity and inflammatory disease. Annual review of pathology 4: 365-398.
34. Geijtenbeek TB, Gringhuis SI, (2009) Signalling through C-type lectin receptors: shaping immune responses. Nature reviews Immunology 9: 465-479.